Kiniksa Pharmaceuticals Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$214,266	$202,127	$180,855	$156,797
Gross Profit	117,893	111,031	97,264	85,763
EBITDA	33,149	23,736	27,541	23,235
EBIT	32,681	23,269	27,157	22,877
Net Income	22,592	14,199	18,435	17,832
Net Change In Cash	214,266	202,127	180,855	156,797
Free Cash Flow	50,038	53,260	33,006	27,925
Cash	189,952	165,596	174,858	192,037
Basic Shares	82,409	78,979	78,027	77,942

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$677,564	$423,239	$270,259	$220,180
Gross Profit	370,150	362,329	213,735	197,285
EBITDA	90,422	-34,457	-14,311	13,428
EBIT	88,868	-36,152	-16,652	11,026
Net Income	59,005	-43,193	14,084	183,363
Net Change In Cash	677,564	423,239	270,259	220,180
Cost of Revenue				245
Free Cash Flow	25,412	25,412	13,171	5,702
Cash	165,596	183,581	107,954	122,715
Basic Shares	78,979	71,424	71,922	70,421